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Hepatitis A virus (HAV) infections occur predominantly in children, and are usually self-limiting. However, 75-95% of the 
infections in adults are symptomatic (mostly with jaundice), with the illness symptoms usually persisting for a few weeks. 
Atypical manifestations include relapsing hepatitis, prolonged cholestasis, and complications involving renal injury. Drug 
rash with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, drug-induced hypersensitivity reaction 
characterized by skin rash, fever, lymph-node enlargement, and internal organ involvement. We describe a 22-year-old 
male who presented with acute kidney injury and was diagnosed with prolonged cholestatic hepatitis A. The patient also 
developed DRESS syndrome due to antibiotic and/or antiviral treatment. To our knowledge, this is the first report of 
histopathologically confirmed DRESS syndrome due to antibiotic and/or antiviral treatment following HAV infection with 
cholestatic features and renal injury. (Korean J Hepatol 2012;18:84-88)
Keywords: Hepatitis A; Drug hypersensitivity; DRESS syndrome; Acute kidney injury
Received May 23, 2011; Revised July 21, 2011; Accepted September 16, 2011
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CMV, cytomegalovirus; DIHS, drug induced hypersensitivity 
syndrome; DRESS, drug rash with eosinophilia and systemic symptoms; EBV, Epstein Barr virus; HAV, hepatitis A virus; PT, prothrombin time;
ULN, upper limit of normal
Corresponding author: Han Chu Lee
Department of Internal Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea
Tel. +82-2-3010-3915, Fax. +82-2-485-5782, E-mail; hch@amc.seoul.kr
Copyright Ⓒ  2012 by The Korean Association for the Study of the Liver
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Hepatitis A is caused by infection with the hepatitis A 
virus (HAV). The HAV is a non-enveloped, positive-stranded 
RNA virus that was first identified using electron 
microscopy in 1973, and is classified within the genus 
hepatovirus of the picornavirus family.
1 Hepatitis A occurs 
predominantly in children, where it is a self-limiting and 
usually asymptomatic infection. However, in adults, 75-95% 
of cases develop jaundice symptoms. The majority of adult 
patients completely recover within 2 months of disease 
onset.
While almost all acute hepatitis A infections subside 
spontaneously without severe complications, some infections 
can be relapsing, prolonged, and involve cholestasis and 
acute kidney injury. HAV-induced fulminant hepatitis is 
rare, with a reported incidence rate of below 0.5%.
2 Recently, 
the incidence of hepatitis A in Korean adults has increased 
rapidly due to the decreased seroprevalence of anti-HAV. 
Thus, there is an increasing number of symptomatic adult 
hepatitis A patients with an unusual clinical course.
3 
Drug rash with eosinophilia and systemic symptoms 
syndrome (DRESS), also known as drug-induced hypersensitivity 
syndrome (DIHS), is a severe idiosyncratic reaction to 
drugs, mainly antiepileptics and antibiotics, and can 
occasionally result in acute liver failure.
4 The characteristics 
of DRESS syndrome include skin rash, fever, lymph node 
enlargement, and internal organ involvement. Although the 
pathophysiology of DRESS syndrome remains unclear, it 
may be due to a defect in detoxification of the causative 
drug, immunological imbalance, or infections such as 
human herpes virus type 6 (HHV6).
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Figure 1. Gross and histological features of the patient. (A) Diffuse erythema with exfoliation throughout the face and dark brownish 
crusts on the eyelids and periorbital area. (B) Diffuse erythematous confluent macules and patches with scales on both posterior legs, 
sparing the popliteal areas. (C) Histological examination of the skin revealed perivascular lymphocytic and eosinophilic infiltration, 
consistent with a drug-associated eruption. Perivascular inflammatory cell cuffing was also noted [hematoxylin and eosin (H-E), ×400].
(D) Liver biopsy findings: (1) an eosinophilic abscess and diffuse infiltration of sinusoidal histiocytes, (2) portal, perivenular, and 
pericellular fibrosis, and (3) moderate portal infiltration by eosinophils (H-E, ×400).
The present report describes the case of a 22-year-old 
male with hepatitis A involving prolonged cholestasis 
and renal injury who developed DRESS syndrome due to 
antibiotic and/or antiviral treatment. To our knowledge, this 
is the first report of histopathologically confirmed DRESS 
syndrome following severe relapsing hepatitis A in an adult.
CASE REPORT
In January 2010, a 22-year-old male presented with acute 
renal failure at another hospital, and was diagnosed with 
acute hepatitis A. He was treated conservatively at that 
hospital for one month, during which time the symptoms and 
laboratory findings improved. At that time he didn’t receive 
any antibiotics. Three days prior to the end of treatment, he 
developed a sudden fever and liver enzyme levels began 
rising again. Oseltamivir was prescribed empirically due to 
the possibility of pandemic swine influenza. One day after 
the administration of oseltamivir, he developed a whole 
body skin rash with intense itching. Records from the 
previous hospital admission indicated a persistent fever 
accompanied by a skin rash, and an abdomino-pelvic 
CT showed gall bladder wall thickening. Consequently, 
cefotaxime and metronidazole antibiotics were prescribed 
due to the suspicion of acute cholecystitis just one day 
before his arrival at our hospital. 
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Figure 2. The clinical course of the patient. ALT, alanine amino-
transferase; AST, aspartate aminotransferase; CMV, cytome-
galovirus.
The patient was referred to our hospital on February 
9th due to the cholestatic hepatitis A, fever and skin rash 
symptoms. The initial vital signs were as follows: blood 
pressure 112/72 mmHg, heart rate 113/min, respiratory rate 
20/min, and body temperature 38.0℃. Laboratory findings 
showed a white blood cell count of 15,900/mm
3, a hemo-
globin level of 11.9 g/dL, a platelet count of 321,000/mm
3, 
an eosinophil count of 2,150/mm
3 (8% [upper limit of 
normal (ULN) 7%]), a serum protein level of 5.0 g/dL, 
a serum albumin level of 1.9 g/dL, a serum aspartate 
aminotransferase (AST) level of 152 IU/L (ULN 40 IU/L), a 
serum alanine aminotransferase (ALT) level of 187 IU/L 
(ULN 40 IU/L), a serum creatinine level of 1.3 mg/dL (ULN 
1.4 mg/dL), a serum total bilirubin level of 25.8 mg/dL 
(ULN 1.2 mg/dL), a serum direct bilirubin level of 15 mg/dL 
(ULN 0.5 mg/dL), and a prothrombin time (PT) (%) level of 
22.4% (normal, 70-140%). The patient tested negative for 
herpes virus, cytomegalovirus (CMV), hepatitis B and C, 
and positive for IgG antibodies against the Epstein Barr 
virus (EBV) and HAV. The patient also tested positive for 
anti-HAV IgM. 
The patient was treated using conservative management 
for the hepatitis A with prolonged cholestasis, including the 
administration of cefotaxime for 4-5 days for the persistent 
fever and jaundice.
By the 4th day after admission to our hospital, the fever 
and skin rash symptoms worsened, prompting a skin biopsy 
(Fig. 1A, B). The biopsy revealed perivascular lymphocytic 
and eosinophilic infiltration, consistent with drug eruption 
(Fig. 1C). After the 8th day of admission, a liver biopsy was 
performed to identify a possible cause of the fever. That 
biopsy revealed an eosinophilic microabscess (Fig. 1D). The 
peripheral blood eosinophil count was 32.4% (6,059/mm
3), 
and laboratory findings showed a total bilirubin level of 23 
mg/dL, an AST level of 110 IU/L, an ALT level of 142 IU/L 
and a serum creatinine level of 4.4 mg/dL.
 Upon consideration of the overall findings, we made a 
diagnosis of DRESS syndrome and prolonged cholestatic 
hepatitis A with renal azotemia. Therefore, cefotaxime 
administration was immediately ceased, and high-dose 
steroid (hydrocortisone 80 mg tid daily) and immunoglobulin 
(1 g/kg/day for 2 days) were administered. After a week of 
high-dose steroid administration, the fever and skin rash 
improved, and prednisolone was then continued at a 
maintenance dose.
After 20 days of treatment, the fever recurred. A CMV 
antigenemia test returned positive findings (41/200,000 
WBC), and a CMV PCR showed 1,097,500 copies/mL. The 
steroid dose was rapidly reduced and ganciclovir was 
administered (Fig. 2). The steroid was discontinued on 
March 28th, and ganciclovir was ceased on April 7th.
Approximately 10 days after steroid discontinuation, the 
serum ALT level rapidly rose to 1,200 IU/L. The patient 
developed another fever and the PT level decreased to 
53.9%. We performed further blood cultures and PCR assays 
for the detection of HAV, CMV and EBV, yet these tests all 
returned negative findings. This led us to suspect recurrent 
DRESS syndrome. Therefore, we commenced steroid pulse 
therapy (methylprednisolone 1 mg/kg/day) on April 14th. 
The patient improved and the steroid dose was tapered 
gradually such that it was 20 mg daily in the form of oral 
prednisone by the time of discharge on April 28th. The 
prednisone was further tapered to 10 mg/day at the 
outpatient clinic. A review in July 2010 showed that liver 
functions had normalized.
DISCUSSION
The incidence of acute hepatitis A in adults has increased 
rapidly during the past 10 years in Korea. The clinical 
manifestations of this infection range from asymptomatic to 
fulminant hepatitis. Less than 30% of infected children are 
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manifest severe hepatitis with markedly elevated liver 
enzymes. Most patients recover uneventfully. However, 
recently in Korea, the incidence of unusual patterns of 
severe hepatitis and renal insufficiency has increased as the 
age of patients with acute hepatitis A has increased.
3 
The unusual clinical manifestations of acute hepatitis A 
include protracted cholestasis, relapse and complications 
involving renal failure.
6 Relapsing hepatitis A occurs in 
3-20% of acute hepatitis A patients,
7 and is characterized by 
a biphasic or polyphasic peak of liver enzyme elevation. 
Relapses occur some weeks or months after the apparent 
recovery, and are marked by the return of symptoms and 
liver enzyme abnormalities. It generally takes less than 3 
weeks for a patient to recover from a recurrent episode. In 
most cases, transaminases and bilirubin levels usually show 
a marked decrease but not a complete normalization during 
this period. The symptoms are usually milder in a relapse 
episode, although cholestasis can occur.
8,9 
The current patient first presented at another hospital with 
renal azotemia, and was diagnosed with acute hepatitis 
A. Over a treatment period of 4 weeks, the transaminase 
levels showed marked improvement, although they 
never completely returned to normal levels. This patient’s 
recurrent episode developed with more severe symptoms 
than the initial episode, possibly due to the development of 
DRESS syndrome. 
Extrahepatic manifestations are unusual in hepatitis A, 
and renal manifestations are even less common. Acute 
kidney injury complicating non-fulminant hepatitis A is 
reported to occur in only 1.5-4.7% of hepatitis A patients.
2 
Kidney injury may be the result of direct renal toxicity due 
to increased bilirubin levels, cryoglobulinemia, alterations 
in renal blood flow due to endotoxemia, and peripheral 
immune complex-mediated damage. In the cholestatic 
variant of hepatitis A, while transaminase levels reduce to 
normal levels, bilirubin levels increase to above 15 mg/dL, 
and may persist in that range for more than 8 weeks. This 
variant can be characterized by pruritus, persistent anorexia, 
diarrhea and weight loss.
10 Although corticosteroids hasten 
the resolution of prolonged cholestatic hepatitis A, they may 
predispose to hepatitis relapse.
11 
In the current patient, the bilirubin level decreased and 
normalized after the administration of corticosteroid. 
However, symptoms returned following the cessation of 
steroid treatment, which is not generally observed when 
corticosteroids are used to treat recurrent hepatitis A.
8 
Hence, we considered that the patient was experiencing 
DRESS syndrome recurrence rather than hepatitis A 
recurrence. The DRESS syndrome recurrence accompanied 
an increase in transaminases but not bilirubin levels.  
The detection of HAV RNA in the plasma after 20 days of 
illness is a predictor of prolonged cholestasis, but it is not a 
predictor of relapsing hepatitis.
12 Acalculous cholecystitis 
may often be a hepatitis A complication, as in the present 
case, and often manifests transiently with spontaneous 
recovery.
2 The current patient presented with various 
forms of atypical manifestations associated with acute 
hepatitis A, including cholestasis and renal injury.
DRESS syndrome is a severe delayed hypersensitivity 
drug reaction that manifests 2-8 weeks after exposure to the 
triggering drug. Our patient was diagnosed with DRESS 
syndrome according to the definition of Bocquet et al.
13 
The diagnostic criteria include the simultaneous presence 
of 3 conditions: 1. Drug-induced skin eruption. 2. Eosi-
nophilia (>1,500/μL). 3. At least one of the following 
systemic abnormalities: enlarged lymph nodes, hepatitis 
(transaminases >2 ULN), interstitial nephropathy, interstitial 
lung disease or myocardial involvement. The hypersensitivity 
reaction is associated with high levels of IL-5 and eosinophil 
accumulation, and may justify the use of steroids. A recent 
report suggests that certain drugs may stimulate a massive 
expansion of drug-specific cytotoxic T cells that destroy 
hepatocytes via a cell-contact-dependent mechanism.
14 
Liver involvement in DRESS syndrome is common and may 
range from a transitory increase in liver enzymes to liver 
necrosis with fulminant hepatic failure.
4 The overall 
mortality in DRESS syndrome is approximately 10%.
15 
DRESS syndrome occurs frequently with concomitant viral 
infection, especially HHV6.
16 It may be that viruses interfere 
with the clearance of the triggering drug and thus induce 
accumulation of a metabolite. 
In the present case, it is still unclear whether DRESS 
syndrome followed acute hepatitis A or developed simply 
after receiving the antibiotics and antiviral agent. The 
association of hepatitis A virus and DRESS syndrome has 
not been reported elsewhere. However, hepatitis A virus 
infection appeared to have triggered DRESS syndrome 
development by reducing the hepatic clearance of drugs, 
leading to an accumulation of drugs and their metabolites. In 
a type of feedback loop, it then appeared that the DRESS 88  The Korean Journal of Hepatology Vol. 18. No. 1, March 2012
syndrome caused the recurrent hepatitis symptoms to be 
worse than the initial symptoms. At this stage we are unable 
to identify which drug triggered the DRESS syndrome. Our 
future plan is to perform patch tests using oseltamivir, 
cefotaxime and metronidazole to identify the causative 
drug once prednisone treatment is ceased. The in vitro 
lymphocyte toxicity assay and lymphocyte transformation 
test also might be helpful. We have recommended that the 
patient avoid exposure to those drugs. 
A recent report showed that the most common causes of 
DRESS syndrome in Korea were antibiotics, followed by 
anticonvulsants.
17 This may reflect that antibiotics may be 
being over-prescribed in Korea. To date, the only undisputed 
treatment for DRESS syndrome is prompt withdrawal of the 
offending drug. Systemic corticosteroid administration is 
particularly recommended in patients with life-threatening 
visceral manifestations that do not respond to drug 
withdrawal.
18 As in the present patient, others have reported 
cases where DRESS syndrome recurred after a short period 
of steroid treatment, which has led some investigators to 
suggest that high-dose systemic steroid may be helpful, and 
that tapering should then be performed slowly.
4 
The final diagnosis in the present case was DRESS 
syndrome due to antibiotic and/or antiviral treatment 
following hepatitis A with cholestatic features and renal 
injury.  There has been only one previous report of a 
histopathologically confirmed case of DRESS syndrome 
following hepatitis A, and that was in a child.
19 To our 
knowledge, the present report is the first to describe a 
histopathologically confirmed case of DRESS syndrome 
following severe cholestatic hepatitis A in an adult.
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